Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.
about
Immunoadsorption therapy for patients with dilated cardiomyopathy and heart failureControlling signaling with a specifically designed Gi-coupled receptorAn experimental approach to study the function of mitochondria in cardiomyopathyCholinergic activity as a new target in diseases of the heartNovel receptor-derived cyclopeptides to treat heart failure caused by anti-β1-adrenoceptor antibodies in a human-analogous rat modelConditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy.Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidismChagas' disease and the autoimmunity hypothesis.Familial dilated cardiomyopathy.Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure.Absence of linkage between idiopathic dilated cardiomyopathy and candidate genes involved in the immune function in a large Italian pedigree.Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance.Impact of human autoantibodies on β1-adrenergic receptor conformation, activity, and internalization.Unresolved issues in theories of autoimmune disease using myocarditis as a frameworkAutoantibodies and cardiovascular dysfunction: cause or consequence?Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy.Improvement of cardiac function after immunoadsorption in patients with dilated cardiomyopathy.Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: an update.Autoantibodies against the β3-adrenoceptor protect from cardiac dysfunction in a rat model of pressure overload.Opposing cardiac effects of autoantibody activation of β-adrenergic and M2 muscarinic receptors in cardiac-related diseases.Mitochondrial Ultrastructural Alterations and Declined M2 Receptor Density Were Involved in Cardiac Dysfunction in Rats after Long Term Treatment with Autoantibodies against M2 Muscarinic ReceptorExpression of a Gi-coupled receptor in the heart causes impaired Ca2+ handling, myofilament injury, and dilated cardiomyopathyAutoimmune myocarditis and dilated cardiomyopathy: focus on cardiac autoantibodies.P2×7 purinergic signaling in dilated cardiomyopathy induced by auto-immunity against muscarinic M2 receptors: autoantibody levels, heart functionality and cytokine expression.Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor.Predictive value of pre-procedural autoantibodies against M2-muscarinic acetylcholine receptor for recurrence of atrial fibrillation one year after radiofrequency catheter ablation.Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy.Atrial tachycardia provoked in the presence of activating autoantibodies to β2-adrenergic receptor in the rabbit.Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.Pathological autoantibodies in cardiomyopathy.Anti-heart autoantibodies in familial dilated cardiomyopathy.Autoantibodies in atrial fibrillation: actor, biomaker or bystander?Immunoadsorption as treatment option in dilated cardiomyopathy.Pathophysiological role of autoantibodies against G-protein-coupled receptors in the cardiovascular system.Association of autoantibodies against the M2-muscarinic receptor with perinatal outcomes in women with severe preeclampsia.The correlation between peripartum cardiomyopathy and autoantibodies against cardiovascular receptors.The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies.The role of the innate immune recognition system in the pathogenesis of primary biliary cirrhosis: a conceptual view.Myocardial regeneration in heart failure: integrated development of biological therapeutic approaches.Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart function
P2860
Q24652847-13B164B0-A2F8-40A0-88B9-55E902C089C4Q24679719-C1D24F20-46DA-44F6-9E7F-A2F3156DB8A5Q26801342-91C6C815-79B1-41F0-8178-475FAEE814FCQ27004543-5DCF0F31-65DE-462D-A01A-1FC056E88FC6Q27315858-E38DC30A-6EE5-4923-B20A-689F6EBA59F8Q30479148-32257A0F-4ACC-4BAA-83BD-745D2CFB382DQ33570881-8C6C4652-E0EE-4C6C-9C4E-01A0A9E83B19Q33588893-86EB5525-FBAA-482B-AB56-5B15BBA18864Q33614491-AB3BDD41-FB7D-4091-BC61-230D1AE3DA76Q33641429-36565CFD-0B11-4E8A-BFDD-9C07E6EB7860Q33675266-BEF84E1C-6E05-4DD0-B6A7-F531D07D8649Q33960727-97E7B34F-AFBC-4A5E-B523-7BA4AB3293AAQ34315311-C437FB32-9223-4500-BD4E-EADC4F59CE69Q34452486-7B1A06C4-4B4D-45B2-801A-5C04C03165BFQ34473885-A0BE9108-6DF8-4396-8324-24D9E3392FA6Q34574067-B06A6FE8-139C-42AF-B66D-446825FE7315Q34574078-C7AE8DB4-C7B1-4ED1-B293-77EA4A75AB8DQ34720542-7980016B-472D-4E06-AAD5-4D2667EE7B63Q35023544-7CD34B4C-BE97-4446-85F8-13DEB39D5460Q35026111-BA51970A-E5D7-41FF-9011-D66D0ECED13EQ35667277-409CB0FC-0073-4A70-A49B-17DD83B092A7Q36022786-72358676-81FC-49AD-8584-C4315DCB6E6DQ36283411-2A2B0788-F701-4BFA-A7A7-A6F39D4D7DB3Q36305471-5F1CB577-05D5-4C4E-A389-B3070C02EBEBQ36365071-728B07D6-5449-46E7-990D-4926F6AA57F3Q36552409-6E3F36CB-26FE-43AC-AE99-C975EE5A9DB3Q36990126-284E60BF-2372-4C17-87B7-FEC9DF619294Q37045274-8C1FD69D-5EED-4350-B417-82972B86769CQ37051232-3A50D056-B328-4C30-AB4C-74EA0599B9ACQ37264371-560FC151-B923-435D-88C1-6530E7AD384FQ37264376-EB13220E-0D8D-41FA-9B2E-53B6E6C333C4Q37264381-BD81846C-C23F-4B45-A5F4-12B16FC38AC9Q37264384-C64750E3-D7C4-4DCF-84DE-2A68620D895AQ37276510-53CA6B01-C96F-4DF6-A159-283B3CD462E3Q37348150-24BDFE2B-E5C8-4511-839B-F8256748D575Q37510542-B7AA60FF-766A-40CC-971F-2FA3EC220C3FQ37826112-71375B01-281D-43DC-90B3-54876A72F5BBQ37898185-8C5ADDD8-3AA3-4AD5-933A-59CD254071DFQ37923971-669A8EB3-76B6-4CAD-BBC5-1D18D70A5DEAQ37973384-CE7EBA48-284A-4C07-A4B8-AEEC3D243E3E
P2860
Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.
description
1993 nî lūn-bûn
@nan
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Localization of a functional a ...... pathic dilated cardiomyopathy.
@ast
Localization of a functional a ...... pathic dilated cardiomyopathy.
@en
type
label
Localization of a functional a ...... pathic dilated cardiomyopathy.
@ast
Localization of a functional a ...... pathic dilated cardiomyopathy.
@en
prefLabel
Localization of a functional a ...... pathic dilated cardiomyopathy.
@ast
Localization of a functional a ...... pathic dilated cardiomyopathy.
@en
P2093
P2860
P356
P1476
Localization of a functional a ...... pathic dilated cardiomyopathy.
@en
P2093
Hjalmarson A
Liljeqvist JA
Magnusson Y
Waagstein F
P2860
P304
P356
10.1172/JCI116416
P407
P577
1993-05-01T00:00:00Z